Search research articles
Contact Us
Filters
Showing results (211-220 of 361) with videos related to
Page
of 37
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
October 27, 2009
Synthesis and evaluation of D-gluco-pyranocyclopropyl amines as potential glucosidase inhibitors
Martijn D P Risseeuw, Richard J B H N van den Berg, Wilma E Donker-Koopman, et al.
Blood Cells, Molecules & Diseases
|
November 9, 2010
A monozygotic twin pair with highly discordant Gaucher phenotypes
M Biegstraaten, I N van Schaik, J M F G Aerts, et al.
The International Journal of Biochemistry & Cell Biology
|
August 2, 2014
Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease
Jenny Serra-Vinardell, Lucía Díaz, Hugo Gutiérrez-de Terán, et al.
American Journal of Hematology
|
March 6, 2012
Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation
Clarence K Zhang, Philip B Stein, Jun Liu, et al.
Journal of Inherited Metabolic Disease
|
August 23, 2024
Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: A first step toward treatment criteria
Eline C B Eskes, Laura van Dussen, Marion M M G Brands, et al.
Haematologica
|
July 10, 2012
Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes
Laura van Dussen, Timothy M Cox, Erik J Hendriks, et al.
Scientific Reports
|
July 9, 2016
Impact of obesity on taste receptor expression in extra-oral tissues: emphasis on hypothalamus and brainstem
D Herrera Moro Chao, C Argmann, M Van Eijk, et al.
Blood Cells, Molecules & Diseases
|
December 4, 2012
Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease
L van Dussen, A Zimran, E M Akkerman, et al.
Journal of Lipid Research
|
March 30, 2007
N-azidoacetylmannosamine-mediated chemical tagging of gangliosides
Anton P Bussink, Paul F van Swieten, Karen Ghauharali, et al.
Molecular Therapy. Methods & Clinical Development
|
January 29, 2021
Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector
Maria Dahl, Emma M K Smith, Sarah Warsi, et al.
Page
of 37
Search research articles
Search
Showing results (211-220 of 361) with videos related to
Sort By:
Page
of 37
Bioorganic & Medicinal Chemistry Letters
|
October 27, 2009
Synthesis and evaluation of D-gluco-pyranocyclopropyl amines as potential glucosidase inhibitors
Martijn D P Risseeuw, Richard J B H N van den Berg, Wilma E Donker-Koopman, et al.
Blood Cells, Molecules & Diseases
|
November 9, 2010
A monozygotic twin pair with highly discordant Gaucher phenotypes
M Biegstraaten, I N van Schaik, J M F G Aerts, et al.
The International Journal of Biochemistry & Cell Biology
|
August 2, 2014
Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease
Jenny Serra-Vinardell, Lucía Díaz, Hugo Gutiérrez-de Terán, et al.
American Journal of Hematology
|
March 6, 2012
Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation
Clarence K Zhang, Philip B Stein, Jun Liu, et al.
Journal of Inherited Metabolic Disease
|
August 23, 2024
Natural disease course of chronic visceral acid sphingomyelinase deficiency in adults: A first step toward treatment criteria
Eline C B Eskes, Laura van Dussen, Marion M M G Brands, et al.
Haematologica
|
July 10, 2012
Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes
Laura van Dussen, Timothy M Cox, Erik J Hendriks, et al.
Scientific Reports
|
July 9, 2016
Impact of obesity on taste receptor expression in extra-oral tissues: emphasis on hypothalamus and brainstem
D Herrera Moro Chao, C Argmann, M Van Eijk, et al.
Blood Cells, Molecules & Diseases
|
December 4, 2012
Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease
L van Dussen, A Zimran, E M Akkerman, et al.
Journal of Lipid Research
|
March 30, 2007
N-azidoacetylmannosamine-mediated chemical tagging of gangliosides
Anton P Bussink, Paul F van Swieten, Karen Ghauharali, et al.
Molecular Therapy. Methods & Clinical Development
|
January 29, 2021
Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector
Maria Dahl, Emma M K Smith, Sarah Warsi, et al.
Page
of 37